APA

Matsuda T., Arakawa N., Takuma K., Kishida Y., Kawasaki Y., Sakaue M., Takahashi K., Takahashi T., Suzuki T., Ota T., Hamano-Takahashi A., Onishi M., Tanaka Y., Kameo K. & Baba A. (20010719). SEA0400, a novel and selective inhibitor of the Na+-Ca2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. : The Journal of pharmacology and experimental therapeutics.

Chicago

Matsuda T, Arakawa N, Takuma K, Kishida Y, Kawasaki Y, Sakaue M, Takahashi K, Takahashi T, Suzuki T, Ota T, Hamano-Takahashi A, Onishi M, Tanaka Y, Kameo K and Baba A. 20010719. SEA0400, a novel and selective inhibitor of the Na+-Ca2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. : The Journal of pharmacology and experimental therapeutics.

Harvard

Matsuda T., Arakawa N., Takuma K., Kishida Y., Kawasaki Y., Sakaue M., Takahashi K., Takahashi T., Suzuki T., Ota T., Hamano-Takahashi A., Onishi M., Tanaka Y., Kameo K. and Baba A. (20010719). SEA0400, a novel and selective inhibitor of the Na+-Ca2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. : The Journal of pharmacology and experimental therapeutics.

MLA

Matsuda T, Arakawa N, Takuma K, Kishida Y, Kawasaki Y, Sakaue M, Takahashi K, Takahashi T, Suzuki T, Ota T, Hamano-Takahashi A, Onishi M, Tanaka Y, Kameo K and Baba A. SEA0400, a novel and selective inhibitor of the Na+-Ca2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. : The Journal of pharmacology and experimental therapeutics. 20010719.